BioHarvest Sciences's total assets for Q2 2026 were $44.57M, a decrease of -6.50% from the previous quarter. DE:8MV0 total liabilities were $24.80M for the fiscal quarter, a 11.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.